Biotech · Private company
TRYP Therapeutics
Track this companyFree. Adds TRYP Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- PsychotherapyPhase 2 · Binge Eating DisorderClinicalTrials.gov · fetched Nov 12, 2026
- PsychotherapyPhase 2 · Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- TRYP-0082Phase 2 · Binge Eating DisorderClinicalTrials.gov · fetched Nov 12, 2026
- TRYP-0082Phase 2 · Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 17, 2024ClinicalTrials.gov NCT06206265 · fetched Nov 12, 2026
- Bioavailability Study of Psilocybin in Normal AdultsPHASE1 · WITHDRAWN · started Jun 1, 2023ClinicalTrials.gov NCT05467761 · fetched Nov 12, 2026
- Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating DisorderPHASE2 · COMPLETED · started Mar 16, 2022ClinicalTrials.gov NCT05035927 · fetched Nov 12, 2026